Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

334
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
334
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.1K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.1K
Drug Therapy01:28

Drug Therapy

108
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
108
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

353
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
353
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

1.0K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons learned from including Patient and Public Involvement members throughout research projects in Tic Disorder research.

Research involvement and engagement·2026
Same author

Development of a tic service model for children and young people in England: a Delphi study.

BMJ open·2026
Same author

The association between emotion regulation strategies, anxiety, autonomic arousal, and quality of life in Malaysian young adults.

Journal of health psychology·2026
Same author

Navigating cultural barriers: a qualitative study exploring clinicians' experiences of providing mental health support for ethnic minority groups in England.

BMC health services research·2026
Same author

Navigating NHS commissioning for digital mental health: a perspective on learning through collaboration.

Frontiers in health services·2025
Same author

'For the love of God, just refer me': a co-produced qualitative study of the experiences of people with Tourette Syndrome and tic disorders accessing healthcare services in the UK.

BMJ open·2025

Related Experiment Video

Updated: Sep 24, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.9K

Current Pharmacological Treatments for ADHD.

Madeleine J Groom1, Samuele Cortese2,3,4,5,6

  • 1Academic Unit of Mental Health and Clinical Neurosciences, School of Medicine, Institute of Mental Health, University of Nottingham, Nottingham, UK. Maddie.Groom@nottingham.ac.uk.

Current Topics in Behavioral Neurosciences
|May 4, 2022
PubMed
Summary

Attention-Deficit Hyperactivity Disorder (ADHD) medications, including stimulants and non-stimulants, effectively treat symptoms and improve life quality. Further research is needed to understand their precise mechanisms and effects on comorbidities.

Keywords:
ADHDAmphetamineClonidineComorbidityEfficacyFunctional outcomesGuanfacineMethylphenidateNonstimulantStimulantTolerabilityTreatment

More Related Videos

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.4K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.9K

Related Experiment Videos

Last Updated: Sep 24, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

15.9K
Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
13:09

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

10.4K
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

5.9K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Child and Adolescent Psychiatry

Background:

  • Attention-Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults.
  • Approved treatments include stimulant and non-stimulant medications.
  • These medications improve ADHD symptoms and functional outcomes but require further research into mechanisms and comorbidities.

Purpose of the Study:

  • To review current pharmacological treatments for ADHD.
  • To summarize mechanisms of action, formulations, efficacy, and side effects of stimulant and non-stimulant medications.
  • To discuss factors influencing treatment decisions and suggest future research directions.

Main Methods:

  • Review of stimulant (methylphenidate, amphetamine) and non-stimulant (atomoxetine, guanfacine, clonidine) medications for ADHD.
  • Summary of mechanisms of action, formulations, efficacy, and tolerability.
  • Discussion of clinical decision-making factors, comorbidities, and medical history.

Main Results:

  • Stimulant and non-stimulant medications are effective in treating ADHD symptoms.
  • These treatments improve quality of life, academic performance, and reduce accident/injury rates.
  • Current medications generally have favorable safety profiles with manageable side effects.

Conclusions:

  • Pharmacological treatments offer significant benefits for individuals with ADHD.
  • Understanding precise mechanisms and effects on comorbidities requires further investigation.
  • Future research should focus on elucidating medication action and impact on co-occurring conditions.